Back to Journals » Vascular Health and Risk Management » Volume 13 » Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance
Please verify you are not a robot.